Orlando, FL-Patients with a common autoimmune disease are 15 timesmore likely to suffer from urinary symptoms associated with interstitialcystitis than age-matched controls, according to the results of a population-basedstudy undertaken by a multi-institutional group of Finnish researchers.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.